CALLIDITAS THERAPEUTICS AB SER'B'NPV financial statements, including revenue, expenses, profit, and loss

The total revenue of 0A5R for the last quarter is 451.56 M SEK, and it's 53.28% higher compared to the previous quarter. The net income of Q4 23 is -18.37 M SEK.